Sci Rep

Identifying multimodal signatures underlying the somatic comorbidity of psychosis: the COMMITMENT roadmap.

Schwarz E, Alnæs D, Andreassen OA, Cao H, Chen J, Degenhardt F, Doncevic D, Dwyer D, Eils R, Erdmann J, Herrmann C, Hofmann-Apitius M, Kaufmann T, Koutsouleris N, Kodamullil AT, Khuntia A, Mucha S, Nöthen MM, Paul R, Pedersen ML, Quintero A, Schunkert H, Sharma A, Tost H, Westlye LT, Zhang Y, Meyer-Lindenberg A.

Mol Psychiatry. 2020 Oct 15. doi: 10.1038/s41380-020-00915-z.

https://pubmed.ncbi.nlm.nih.gov/33060817/

Identifying multimodal signatures underlying the somatic comorbidity of psychosis: the COMMITMENT roadmap. Read More »

A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors.

Brænne I, Willenborg C, Tragante V, Kessler T, Zeng L, Reiz B, Kleinecke M, von Ameln S, Willer CJ, Laakso M, Wild PS, Zeller T, Wallentin L, Franks PW, Salomaa V, Dehghan A, Meitinger T, Samani NJ, Asselbergs FW, Erdmann J, Schunkert H.

Sci Rep. 2017 Aug 31;7(1):10252. doi: 10.1038/s41598-017-10928-4.

https://www.ncbi.nlm.nih.gov/pubmed/28860667

A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors. Read More »

Scroll to Top